| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
8 companies
Versant Venture Capital Vi, L.P. is a 10% Owner at IPSC with holdings across 8 companies. Recent SEC Form 4 filings include 0 buys and 38 sells.
Estimated insider holdings value: $97.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 224,974 | $46.01 | $10,352,017.45 | -3.9% | -64.5% | - | |
| Sep 18, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 135,304 | $42.23 | $5,714,356.00 | -2.1% | -60.7% | - | |
| Aug 26, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 188,094 | $39.47 | $7,423,920.06 | -1.4% | -17.3% | - | |
| Aug 18, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 260,713 | $39.34 | $10,255,243.56 | -5.2% | -33.7% | - | |
| Jul 10, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 191,376 | $34.00 | $6,506,784.00 | -10.8% | +41.9% | - | |
| Jun 27, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 200,000 | $30.47 | $6,093,000.00 | -10.2% | +32.6% | - | |
| Jun 20, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 334,801 | $30.19 | $10,107,817.95 | -7.4% | +39.2% | - | |
| Jun 10, 2025 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Sell | 350,000 | $29.00 | $10,150,000.00 | -21.9% | +41.1% | - | |
| Oct 29, 2024 | GLUE Monte Rosa Therapeutics, Inc. | 10% Owner | Sell | 157,895 | $9.44 | $1,491,041.14 | -3.0% | -38.6% | +33.4% | |
| Sep 20, 2024 | GLUE Monte Rosa Therapeutics, Inc. | 10% Owner | Sell | 1,132,566 | $6.53 | $7,395,202.95 | -18.2% | +0.5% | -2.3% |